Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Alterity Therapeutics Limited PRNAF

Set alert

Price alert · PRNAF

All alert types
0.25 USD 0.00 0.00%

At close · Oct 30

0.25 Day range 0.25
0.0002 52-week range 0.5501
YTD
+3,868.25%
1 year
+3,471.43%
Open
0.25
Prev close
0.25
Mkt cap
57.28M
Vol
2.50K
Avg vol
78
EPS
-0.08
P/E
0.00
More statistics
Low
0.25
High
0.25

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for PRNAF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

6.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -0.0×
FY 2017: -3.2×FY 2018: -1.7×FY 2019: -0.0×FY 2020: -3.2×FY 2021: -3.1×FY 2022: -2.9×FY 2023: -5.9×FY 2024: -0.8×FY 2025: -2.4×FY 2026: -0.0×
FY 2017 5y median -2.4× FY 2026
P/S 0.0×
FY 2017: 183×FY 2018: 71.6×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 10.7×FY 2022: 7.1×FY 2023: 20.8×FY 2024: 4.0×FY 2025: 5.4×FY 2026: 0.0×
FY 2017 5y median 5.4× FY 2026
P/B 0.0×
FY 2017: 1.0×FY 2018: 0.9×FY 2019: 0.0×FY 2020: 4.1×FY 2021: 1.5×FY 2022: 1.0×FY 2023: 3.6×FY 2024: 1.2×FY 2025: 0.7×FY 2026: 0.0×
FY 2017 5y median 1.0× FY 2026
P/FCF 0.0×
FY 2017: -4.1×FY 2018: -2.3×FY 2019: -0.0×FY 2020: -4.6×FY 2021: -2.7×FY 2022: -2.9×FY 2023: -4.1×FY 2024: -1.3×FY 2025: -2.5×FY 2026: 0.0×
FY 2017 5y median -2.5× FY 2026
EV/EBITDA 1.3×
FY 2017: -0.3×FY 2018: 0.1×FY 2019: 1.1×FY 2020: -2.5×FY 2021: -1.2×FY 2022: -0.1×FY 2023: -4.5×FY 2024: -0.2×FY 2025: 0.3×FY 2026: 1.3×
FY 2017 5y median -0.1× FY 2026
EV/Sales 0.0×
FY 2017: 18.0×FY 2018: -4.2×FY 2019: -2.9×FY 2020: 0.0×FY 2021: 4.3×FY 2022: 0.4×FY 2023: 16.9×FY 2024: 0.8×FY 2025: -0.7×FY 2026: 0.0×
FY 2017 5y median 0.4× FY 2026
FCF Yield 0.0%
FY 2017: -24.3%FY 2018: -43.8%FY 2019: -15797.2%FY 2020: -21.8%FY 2021: -37.2%FY 2022: -34.0%FY 2023: -24.6%FY 2024: -79.4%FY 2025: -39.3%FY 2026: 0.0%
FY 2017 5y median -34.0% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 83.9%FY 2018: 89.2%FY 2019: 93.5%FY 2020: 0.0%FY 2021: 91.7%FY 2022: 98.9%FY 2023: 97.4%FY 2024: 94.7%FY 2025: 97.7%FY 2026: 0.0%
FY 2017 5y median 97.4% FY 2026
Operating Margin 0.0%
FY 2017: -5197.9%FY 2018: -5281.6%FY 2019: -255.7%FY 2020: 0.0%FY 2021: -349.7%FY 2022: -302.5%FY 2023: -373.0%FY 2024: -487.7%FY 2025: -268.0%FY 2026: 0.0%
FY 2017 5y median -302.5% FY 2026
Net Margin 0.0%
FY 2017: -5696.6%FY 2018: -4108.8%FY 2019: -249.2%FY 2020: 0.0%FY 2021: -352.8%FY 2022: -250.7%FY 2023: -352.5%FY 2024: -475.8%FY 2025: -223.4%FY 2026: 0.0%
FY 2017 5y median -250.7% FY 2026
ROE -54.8%
FY 2017: -31.8%FY 2018: -51.4%FY 2019: -74.5%FY 2020: -127.6%FY 2021: -50.2%FY 2022: -36.2%FY 2023: -60.5%FY 2024: -138.6%FY 2025: -28.6%FY 2026: -54.8%
FY 2017 5y median -54.8% FY 2026
ROIC -57.6%
FY 2017: -29.0%FY 2018: -66.1%FY 2019: -76.3%FY 2020: -130.7%FY 2021: -49.7%FY 2022: -43.5%FY 2023: -63.4%FY 2024: -140.4%FY 2025: -34.2%FY 2026: -57.6%
FY 2017 5y median -57.6% FY 2026
ROA -50.9%
FY 2017: -29.8%FY 2018: -44.1%FY 2019: -62.0%FY 2020: -101.1%FY 2021: -45.6%FY 2022: -31.1%FY 2023: -50.5%FY 2024: -99.5%FY 2025: -26.4%FY 2026: -50.9%
FY 2017 5y median -50.5% FY 2026

Growth (YoY)

Revenue -100.0%
FY 2017: -7.2%FY 2018: 51.9%FY 2019: 2361.1%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 18.1%FY 2023: -23.6%FY 2024: 2.6%FY 2025: 35.3%FY 2026: -100.0%
FY 2017 FY 2026
Operating Income -94.7%
FY 2017: 19.9%FY 2018: -54.4%FY 2019: -19.2%FY 2020: -9.7%FY 2021: -9.3%FY 2022: -2.1%FY 2023: 5.8%FY 2024: -34.2%FY 2025: 25.6%FY 2026: -94.7%
FY 2017 FY 2026
EPS (diluted) -15.8%
FY 2017: 2.8%FY 2018: -9.9%FY 2019: -29.0%FY 2020: 25.0%FY 2021: 40.0%FY 2022: 41.1%FY 2023: -7.5%FY 2024: 8.8%FY 2025: 63.5%FY 2026: -15.8%
FY 2017 FY 2026
Free Cash Flow 100.0%
FY 2017: 20.6%FY 2018: -7.0%FY 2019: -121.3%FY 2020: 32.3%FY 2021: -83.5%FY 2022: 28.3%FY 2023: -61.3%FY 2024: 37.1%FY 2025: 9.2%FY 2026: 100.0%
FY 2017 FY 2026

Financial Health

Current Ratio 14.5×
FY 2017: 15.9×FY 2018: 7.1×FY 2019: 6.0×FY 2020: 4.9×FY 2021: 10.9×FY 2022: 7.1×FY 2023: 6.2×FY 2024: 3.5×FY 2025: 13.0×FY 2026: 14.5×
FY 2017 5y median 7.1× FY 2026
Quick Ratio 14.5×
FY 2017: 15.7×FY 2018: 7.0×FY 2019: 5.8×FY 2020: 4.7×FY 2021: 10.9×FY 2022: 6.8×FY 2023: 5.6×FY 2024: 3.5×FY 2025: 13.0×FY 2026: 14.5×
FY 2017 5y median 6.8× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.3×
FY 2017: 3.2×FY 2018: 1.9×FY 2019: 1.1×FY 2020: 0.7×FY 2021: 1.9×FY 2022: 2.2×FY 2023: 1.1×FY 2024: 0.6×FY 2025: 2.3×FY 2026: 1.3×
FY 2017 5y median 1.3× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30